Sufferers with relapsed or refractory B-cell acute lymphoblastic leukemia may have a brand new therapy choice following the FDA's approval of Aucatzyi. The...
Utilizing post-transplant cyclophosphamide (PTCY) for graft-versus-host illness prophylaxis in sufferers with myelodysplastic syndromes is a sound choice in comparison with antithymocyte globulin (ATG).Graft-versus-host...
Some sufferers with superior leiomyosarcoma who had illness worsening after first-line chemotherapy might profit from Bavencio and gemcitabine. Remedy with Bavencio (avelumab) and...
